Publication | Closed Access

An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells

Breast OncologyReceptor Tyrosine KinaseBreast Cancer CellsImmunologyBreast CancerExtracellular Signal-regulated KinaseMedicineCell BiologyCell SignalingTumor MicroenvironmentTumor BiologyCancer Growth